{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:53:54Z","timestamp":1779000834523,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016047","name":"Fond za nauku Republike Srbije","doi-asserted-by":"publisher","award":["7005"],"award-info":[{"award-number":["7005"]}],"id":[{"id":"10.13039\/501100016047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Republic of Serbia Ministry of Education Science and Technological Development","doi-asserted-by":"publisher","award":["451-03-136\/2025-03\/200026"],"award-info":[{"award-number":["451-03-136\/2025-03\/200026"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Republic of Serbia Ministry of Education Science and Technological Development","doi-asserted-by":"publisher","award":["451-03-136\/2025-03\/200168"],"award-info":[{"award-number":["451-03-136\/2025-03\/200168"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Republic of Serbia Ministry of Education Science and Technological Development","doi-asserted-by":"publisher","award":["451-03-136\/2025-03\/200288"],"award-info":[{"award-number":["451-03-136\/2025-03\/200288"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Republic of Serbia Ministry of Education Science and Technological Development","doi-asserted-by":"publisher","award":["451-03-136\/2025-03\/200007"],"award-info":[{"award-number":["451-03-136\/2025-03\/200007"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bioorg.2025.109307","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:58:14Z","timestamp":1764403094000},"page":"109307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity"],"prefix":"10.1016","volume":"168","author":[{"given":"Ljiljana","family":"Kora\u010dak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Ajda\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milica","family":"Selakovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milica","family":"Pajovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav","family":"Novakovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ema","family":"Lup\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Podolski-Reni\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Zlatovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milica","family":"Pe\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor M.","family":"Opsenica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2025.109307_bb0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1021\/acsomega.9b02600","article-title":"Synthesis and evaluation of artemisinin-based hybrid and dimer derivatives as Antimelanoma agents","volume":"5","author":"Botta","year":"2020","journal-title":"ACS Omega"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109307_bb0010","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acsmedchemlett.8b00381","article-title":"Synthesis of artemisinin\u2013estrogen hybrids highly active against HCMV, P. falciparum, and cervical and breast cancer","volume":"9","author":"Fr\u00f6hlich","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109307_bb0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/tropicalmed9090223","article-title":"Antimalarial mechanisms and resistance status of artemisinin and its derivatives","volume":"9","author":"Zheng","year":"2024","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.109307_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.828856","article-title":"Repurposing artemisinin and its derivatives as anticancer drugs: a chance or challenge?","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109307_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112044","article-title":"Artemisinin-derived hybrids and their anticancer activity","volume":"188","author":"Gao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_bb0030","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2174\/138955710791608280","article-title":"Recent Progress in the development of synthetic hybrids of natural or unnatural bioactive compounds for medicinal chemistry","volume":"10","author":"Tsogoeva","year":"2010","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_bb0035","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.3390\/pharmaceutics15092185","article-title":"Molecular hybridization as a strategy for developing artemisinin-derived anticancer candidates","volume":"15","author":"Marchesi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2025.109307_bb0040","first-page":"25","article-title":"A review on recent advances in nitrogen-containing molecules and their biological applications","volume":"2020","author":"Kerru","year":"1909","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109307_bb0045","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1021\/jm501100b","article-title":"Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals","volume":"57","author":"Vitaku","year":"2014","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109307_bb0050","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1021\/acs.jmedchem.0c01786","article-title":"FDA approved drugs from 2015\u2013June 2020: a perspective","volume":"64","author":"Bhutani","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129833","article-title":"Synthesis and biological activity of pyrimidines-containing hybrids: focusing on pharmacological application","volume":"1230","author":"Zarenezhad","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109307_bb0060","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1016\/j.bmcl.2018.10.010","article-title":"Design and synthesis of a novel series of non-nucleoside HIV-1 inhibitors bearing pyrimidine and N-substituted aromatic piperazine","volume":"28","author":"Jin","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109307_bb0065","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.3390\/ijms22083825","article-title":"Novel pyrimidine derivatives as potential anticancer agents: synthesis, biological evaluation and molecular docking study","volume":"22","author":"Tyli\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109307_bb0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bioorg.2018.03.030","article-title":"Design, synthesis and evaluation of some pyrazolo [3, 4-d] pyrimidines as anti-inflammatory agents","volume":"78","author":"Tageldin","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115701","article-title":"Heterocyclic pyrimidine derivatives as promising antibacterial agents","volume":"259","author":"Ahmed","year":"2023","journal-title":"Eur. J. Med.Chem."},{"key":"10.1016\/j.bioorg.2025.109307_bb0080","article-title":"Significance and biological importance of pyrimidine in the microbial world","author":"Sharma","year":"2014","journal-title":"Int. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109307_bb0085","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1080\/14756366.2021.1931861","article-title":"Piperazine skeleton in the structural modification of natural products: a review","volume":"36","author":"Zhang","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_bb0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11094-022-02597-z","article-title":"Piperazine heterocycles as potential anticancer agents: a review","volume":"56","author":"Al-Ghorbani","year":"2022","journal-title":"Pharm. Chem. J."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109307_bb0095","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.bmc.2005.10.032","article-title":"Synthesis and antimicrobial activity of N-alkyl and N-aryl Piperazine derivatives","volume":"14","author":"Chaudhary","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2025.109307_bb0100","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1016\/j.bmcl.2012.08.071","article-title":"Synthesis and biological evaluation of Novel Piperazine derivatives of flavone as potent anti-inflammatory and antimicrobial agent","volume":"22","author":"Hatnapure","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109307_bb0105","doi-asserted-by":"crossref","first-page":"16931","DOI":"10.1039\/D1RA02426D","article-title":"Synthesis and biological evaluation of a New class of multi-target heterocycle Piperazine derivatives as potential antipsychotics","volume":"11","author":"Gao","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109307_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.nbd.2019.03.028","article-title":"New Piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease","volume":"129","author":"Sergeant","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109307_bb0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/acs.jmedchem.7b01138","article-title":"Alkylated Piperazines and Piperazine-azole hybrids as antifungal agents","volume":"61","author":"Chandrika","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_bb0120","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ejmech.2017.10.028","article-title":"Synthesis of Piperazine sulfonamide analogs as diabetic-II inhibitors and their molecular docking study","volume":"141","author":"Taha","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_rf0125","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1039\/D3NJ00427A","article-title":"Novel artesunate\u2013pyrimidine-based hybrids with anticancer potential against multidrug-resistant cancer cells","volume":"47","author":"Kora\u010dak","year":"2023","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_rf0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104496","article-title":"Novel artemisinin derivatives with potent anticancer activities and the anti-colorectal cancer effect by the mitochondria-mediated pathway","volume":"106","author":"Lin","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_rf0135","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/cbdd.13016","article-title":"Synthesis and evaluation of cytotoxic activities of artemisinin derivatives","volume":"90","author":"Sun","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.109307_bb0130","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.bmc.2019.07.005","article-title":"1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: a recent overview","volume":"27","author":"Bozorov","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109307_bb0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1871520616666160811113531","article-title":"Recent advancements in 1,4-Disubstituted 1H-1,2,3-Triazoles as potential anticancer agents","volume":"18","author":"Lal","year":"2018","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_bb0140","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1016\/j.bmcl.2018.09.021","article-title":"1,2,3-Triazole fused with pyridine\/pyrimidine as new template for antimicrobial agents: Regioselective synthesis and identification of potent N-heteroarenes","volume":"28","author":"Marepu","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"37","key":"10.1016\/j.bioorg.2025.109307_bb0145","doi-asserted-by":"crossref","first-page":"13066","DOI":"10.1002\/anie.201907224","article-title":"Artemisinin\u2013(Iso)quinoline hybrids by C\u2212H activation and click chemistry: combating multidrug-resistant malaria","volume":"58","author":"\u00c7apc\u0131","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.109307_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116235","article-title":"Design, synthesis, and molecular modeling studies of novel 2-quinolone-1,2,3-triazole-\u03b1-aminophosphonates hybrids as dual antiviral and antibacterial agents","volume":"268","author":"El Gadali","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2025.109307_bb0155","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.3390\/molecules28227495","article-title":"Quercetin-1,2,3-Triazole hybrids as multifunctional anti-Alzheimer\u2019s agents","volume":"28","author":"Carreiro","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109307_bb0160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/genes16040453","article-title":"Association of ABC efflux transporter genetic variants and adverse drug reactions and survival in patients with non-small lung Cancer","volume":"16","author":"Souto Seguin","year":"2025","journal-title":"Genes"},{"key":"10.1016\/j.bioorg.2025.109307_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11171","article-title":"P-glycoprotein and cancer: what do we currently know?","volume":"8","author":"Pilotto Heming","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.bioorg.2025.109307_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112604","article-title":"Design, synthesis and biological activities of novel pleuromutilin derivatives with a substituted triazole moiety as potent antibacterial agents","volume":"204","author":"Zhang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_bb0175","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/acsomega.7b00310","article-title":"Synthesis of Novel hybrids of Quinazoline and artemisinin with high activities against plasmodium falciparum, human cytomegalovirus, and leukemia cells","volume":"2","author":"Fr\u00f6hlich","year":"2017","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109307_rf0190","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1021\/np100852p","article-title":"Efficient total synthesis of (+)-dihydropinidine, (\u2212)-epidihydropinidine, and (\u2212)-pinidinone","volume":"74","author":"Kavala","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.109307_rf0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115035","article-title":"Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potential","volume":"247","author":"Slavish","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113000","article-title":"Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers","volume":"211","author":"Zhou","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_bb0190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drup.2012.03.002","article-title":"Collateral sensitivity as a strategy against cancer multidrug resistance","volume":"15","author":"Pluchino","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bioorg.2025.109307_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.862743","article-title":"The relationship of redox with hallmarks of Cancer: the importance of homeostasis and context","volume":"12","author":"Xing","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2025.109307_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/srep44541","article-title":"Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles","volume":"7","author":"Lopes-Rodrigues","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109307_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106997","article-title":"Recent developments of P-glycoprotein inhibitors and its structure\u2013activity relationship (SAR) studies","volume":"143","author":"Zhao","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109307_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108675","article-title":"Efflux mechanism and pathway of verapamil pumping by human P-glycoprotein","volume":"696","author":"Wang","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109307_bb0215","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bcp.2014.10.006","article-title":"Tariquidar inhibits P-glycoprotein drug efflux but activates ATPase activity by blocking transition to an open conformation","volume":"92","author":"Loo","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109307_bb0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/antiox13020215","article-title":"Regulation of P-glycoprotein during oxidative stress","volume":"13","author":"Shchulkin","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.bioorg.2025.109307_bb0225","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/s41467-025-58561-4","article-title":"Cryo-EM of human P-glycoprotein reveals an intermediate occluded conformation during active drug transport","volume":"16","author":"Culbertson","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.109307_bb0240","series-title":"Schr\u00f6dinger Release 2021\u20131: Maestro","year":"2021"},{"key":"10.1016\/j.bioorg.2025.109307_bb0245","series-title":"Schr\u00f6dinger Release 2021\u20131: Glide","year":"2021"},{"key":"10.1016\/j.bioorg.2025.109307_bb0250","series-title":"Dassault Syst\u00e8mes, Discovery Studio Client 2024","author":"BIOVIA","year":"2021"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:06:18Z","timestamp":1768399578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825011873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"alternative-id":["S0045206825011873"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109307","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109307"}}